Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2013
10/30/2013CN103372168A Chinese medicinal composition for treating night sweating
10/30/2013CN103372154A Chinese medicinal composition for treating fever with cold limbs
10/30/2013CN103372086A Traditional Chinese medicine-based health care and epidemic prevention method for laying hen breeding
10/30/2013CN102552239B Method for preparing anti-inflammatory and anti-tumor active ingredient group from liquorice dregs and application thereof
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102188693B Proteoglycan complex
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
10/29/2013US8569260 N-pyrazole A2A receptor agonists
10/29/2013US8569248 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
10/29/2013US8569058 Nerve regeneration promoters
10/29/2013US8568799 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
10/29/2013CA2529268C Pharmaceutical formulations of amyloid inhibiting compounds
10/29/2013CA2477406C Dna vaccine against proliferating endothelial cells and methods of use thereof
10/29/2013CA2466128C Antibodies to cd40
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/29/2013CA2396992C Hybrid cells
10/29/2013CA2382120C Single-stranded oligodeoxynucleotide mutational vectors
10/24/2013WO2013158046A1 Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
10/24/2013WO2013157583A1 Novel carbapenem compound
10/24/2013WO2013157562A1 Nitrogenated bicyclic aromatic heterocyclic compound
10/24/2013WO2013157555A1 Novel aplysiatoxin derivative and anticancer agent containing same
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157528A1 Bicyclic compound
10/24/2013WO2013157003A1 Growth enhancement of infants
10/24/2013WO2013155585A1 Sustained release device for thalidomide and use in eye diseases causing neovascularisation
10/24/2013WO2013134081A3 Halogenated compounds for photodynamic therapy
10/24/2013US20130281522 Methods for alzheimer's disease treatment and cognitive enhancement
10/24/2013US20130280234 Treatment and Composition for Wound Healing
10/23/2013EP2653157A1 Astaxanthin for improving muscle atrophy
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP1842557B1 Drug carrier and drug carrier kit for inhibiting fibrosis
10/23/2013CN103370070A Novel antibacterial compounds, methods of making them, and uses thereof
10/23/2013CN103370056A Absorbent dressings with painkilling activity
10/23/2013CN103356997A Pharmaceutical compositions comprising HGH for oral delivery
10/23/2013CN103356996A Treatment of acute coronary syndrome with GLP-1
10/23/2013CN103356987A Ephedra-containing traditional Chinese medicine and its preparation method
10/23/2013CN103356751A Exact composition for strengthening sexual function and promoting regrowth of male sexual organ
10/23/2013CN103356708A Method for manufacturing medicine for preventing hernia after operation
10/23/2013CN103356652A Application of Chukrasone A in preparing MAO (Monoamine Oxidase) inhibitor medicines
10/23/2013CN103356544A Application of Sarcaboside B in monoamine oxidase inhibitor drug
10/23/2013CN102743701B Pharmaceutical composition for resisting heat stress of broiler chickens
10/23/2013CN102406707B Normal-temperature preparation method of ultramicro Scutellaria baicalensis powder and special bidirectional airflow screening machine thereof
10/23/2013CN102370666B Special lyophilized water beetle powder for athletes, and preparation method thereof
10/23/2013CN102210800B Application of citron daylily and citron daylily general flavone
10/23/2013CN102008407B Composite essential oil for modifying face shape
10/23/2013CN101679298B Fused bicyclic heteroaryl derivatives
10/22/2013US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs)
10/22/2013US8563514 Peptides and pharmaceutical compositions for treating connective tissue
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562968 Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia
10/22/2013CA2599112C Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
10/22/2013CA2474344C Expansion of renewable stem cell populations
10/22/2013CA2457488C Antimicrobial agent
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2367750C Tribonectins
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155365A1 Markers for diagnosing amyotrophic lateral sclerosis
10/17/2013WO2013154410A1 Use of phenobarbital (phb) in small doses in the treatment of autonomic dysregulations such as sympathetic hyperactivity
10/17/2013WO2013154209A1 Antiprotozoan composition containing caspofungin or its salt and biguanide compound or its salt
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013WO2013154163A1 Novel 5-aryl-1,2-thiazinane derivative
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153821A1 Pdk4 inhibitor and use thereof
10/17/2013WO2013153117A1 Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics
10/17/2013US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130273651 Differentiated cells suitable for human therapy
10/17/2013US20130273075 Compounds and Method for Modulating Inflammatory Reactions
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/17/2013US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
10/16/2013EP2650361A1 Galectin 9-secreting cell, production method for same, and application for same
10/16/2013EP2649075A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
10/16/2013EP2649066A1 Hydantoin derivatives useful as kv3 inhibitors
10/16/2013EP2648758A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
10/16/2013EP2648737A1 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN103349757A Traditional Chinese medicine composition for treating fire excess from yin deficiency
10/16/2013CN103349744A Heatstroke-preventing cooling oral liquid and preparation method thereof
10/16/2013CN101935301B Modulators of ATP-binding cassette transporters
10/16/2013CN101760377B Manufacturing method of wine for reducing internal heat
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013CA2767092C Novel compounds, pharmaceutical compositions containing same and methods of use for same
10/15/2013CA2487732C Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/15/2013CA2373721C Compounds that bind her2
10/10/2013WO2013150771A1 Composition and method for the safe and effective inhibition of pancreatic lipase in mammals
10/10/2013WO2013150534A1 Novel targeting agents for diagnostic and therapeutic indications
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130266553 Albumin Fusion Proteins
10/09/2013EP2647721A1 Peptide with safer secondary structure, peptide library, and production methods for same
10/09/2013EP2647708A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
10/09/2013EP2647385A1 Tie2 ACTIVATOR, VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, ANTI-ANGIOGENIC AGENT, AGENT FOR MATURING BLOOD VESSELS, AGENT FOR NORMALIZING BLOOD VESSELS, AGENT FOR STABILIZING BLOOD VESSELS, AND PHARMACEUTICAL COMPOSITION
10/09/2013EP2647383A1 Breast enhancement accelerator
10/09/2013EP2647381A1 Orally disintegrating tablet
10/09/2013CN103347566A Hypotonic aqueous composition with reduced chloride content, with or without phospholipids
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 1564